MetLife Investment Management’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,077
Closed -$786K 2911
2024
Q2
$786K Buy
23,077
+3,665
+19% +$109K ﹤0.01% 1478
2024
Q1
$683K Hold
19,412
﹤0.01% 1515
2023
Q4
$561K Buy
19,412
+1,258
+7% +$30K ﹤0.01% 1619
2023
Q3
$416K Buy
18,154
+2,106
+13% +$111K ﹤0.01% 1748
2023
Q2
$920K Buy
16,048
+2,503
+18% +$131K 0.01% 1308
2023
Q1
$510K Buy
13,545
+360
+3% +$13.3K ﹤0.01% 1625
2022
Q4
$353K Sell
13,185
-1,597
-11% -$43.6K ﹤0.01% 1862
2022
Q3
$418K Buy
14,782
+2,614
+21% +$72.9K ﹤0.01% 1761
2022
Q2
$264K Hold
12,168
﹤0.01% 2115
2022
Q1
$489K Buy
12,168
+4,491
+58% +$188K ﹤0.01% 1787
2021
Q4
$364K Hold
7,677
﹤0.01% 1677
2021
Q3
$435K Hold
7,677
﹤0.01% 1597
2021
Q2
$441K Buy
7,677
+1,047
+16% +$57.6K ﹤0.01% 1642
2021
Q1
$420K Hold
6,630
﹤0.01% 1629
2020
Q4
$222K Hold
6,630
﹤0.01% 1921
2020
Q3
$181K Hold
6,630
﹤0.01% 1915
2020
Q2
$179K Buy
+6,630
New +$124K ﹤0.01% 1971

Other funds holding MORF

MetLife Investment Management's MORF Position: Q3 2024 in Review

MetLife Investment Management sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 23,077 shares — an estimated $786K sold.

MetLife Investment Management first reported a position in MORF in Q2 2020 and held it in 17 quarters. The position peaked at $920K in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • MetLife Investment Management reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • MetLife Investment Management sold 23,077 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $786K.
  • MetLife Investment Management first reported a position in Morphic Holding, Inc. Common Stock in Q2 2020 and held it in 17 quarters.
  • MetLife Investment Management's Morphic Holding, Inc. Common Stock position peaked at $920K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on MetLife Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.